Abstract
This study was designed to evaluate the significance of aneuploidy in DNA ploidy, nuclear area, and expression of P-glycoprotein (P-GP) in differentiating drug-resistant myeloid leukemic cells (DRMLC) from drug-sensitive myeloid leukemic cells. Bone marrow aspirates from 28 myeloid leukemic patients were fixed in 95% ethanol solution and stained using the Papanicolaou method. The nuclear area and DNA content were measured. An immunohistochemical study was performed using monoclonal antibody (JSB-1) directed against P-GP. Leukemic cell morphology changed once or twice after the diagnosis of acute myeloid leukemia (AML), blastic crisis (BC) of chronic myeloid leukemia, or chronic neutrophilic leukemia. DRMLC showed severe atypia and were morphologically distinguishable from normal myeloblasts, promyelocytes, and drug-sensitive leukemic cells at the diagnosis of AML or BC. The mean nuclear index (NI) and DNA index (DI) of DRMLC were significantly larger than those of drug-sensitive leukemic cells of AML or BC. The frequency of aneuploidy and P-GP expression was 9.1% and 4.5%, respectively, at the diagnosis of AML or BC, and 92.8% and 28.5%, respectively, for resistant disease. The incidence of heterogeneity in DNA ploidy was 86.3%...Continue Reading
References
Jul 1, 1991·British Journal of Haematology·J M BennettC Sultan
Jan 1, 1991·British Journal of Haematology·P MustoM Carotenuto
Jul 1, 1990·British Journal of Haematology·H SatoA Gottlieb
Jan 1, 1991·Leukemia Research·P BronsJ Boezeman
May 15, 1991·Journal of the National Cancer Institute·R PirkerL Havelec
Jan 1, 1990·Leukemia Research·C TarellaD Ferrero
Mar 1, 1990·Cancer·D E Merkel, W L McGuire
Sep 1, 1985·Annals of Internal Medicine·J M BennettC Sultan
Sep 15, 1988·International Journal of Cancer. Journal International Du Cancer·R J ScheperJ Lankelma
Nov 29, 1986·Lancet·J K ReesF G Hayhoe
Jan 17, 1987·Lancet·D D MaD R Bell
Jan 1, 1987·Acta Haematologica·M J KeatingE J Freireich
Jan 15, 1988·Cancer·O P KallioniemiT Koivula
Jun 1, 1986·Cancer·W HiddemannT Büchner
May 1, 1987·Cancer·P SmitsC Haanen
Dec 1, 1987·Investigational New Drugs·D A VorobiofA P Terblanche
May 28, 1987·The New England Journal of Medicine·I Pastan, M Gottesman
Oct 1, 1985·Annals of Internal Medicine·J M BennettC Sultan
Aug 1, 1985·European Journal of Cancer & Clinical Oncology·P S MitrouH Bartels
Sep 1, 1984·British Journal of Haematology·H D PreislerK Rai
Oct 1, 1984·American Journal of Clinical Oncology·J M BennettM M Oken
Jan 1, 1983·Histochemistry·S Hamada, S Fujita
Jan 1, 1984·American Journal of Hematology·G Cantin, J K Brennan
Jan 1, 1982·Medical and Pediatric Oncology·A P EarlyJ A McBride
Jan 15, 1994·Cancer·M ItsuboM Tanaka
Apr 1, 1994·Leukemia Research·K Nooter, P Sonneveld
Nov 15, 1993·Cancer·T SutoK Saito
Dec 15, 1993·Cancer·K KaketaniM Kobayashi